One patient cannot bear a bedsheet touching their feet. Another cannot feel a nail through their shoe. Both have diabetic neuropathy, and the second is in more danger than the first.
SGLT2 inhibitors were developed to lower blood sugar by making you urinate it out. The glucose effect turned out to be the least interesting thing about them, and the kidney trials changed how this complication is treated.
Fear, disrupted sleep, grief and irritability are common during conflict. Evidence-based support begins with safety and practical care, while recognizing when professional help is urgent.
New survey analysis points to greater climate-related health harm among disabled people, strengthening the case for accessible alerts, evacuation and cooling plans.
Updated traveler attention around Ebola-affected areas underscores a basic rule: monitor official advice, know the symptoms and seek help without stigmatizing whole countries.
New research on mindful technology use reframes burnout as a work-design problem involving notifications, norms and control, not just an employee resilience problem.
Doctors and followers spent a year disagreeing about nizam al-tayyibat without ever contradicting each other, because they were not answering the same question.
A delayed mortality count reveals the June heatwave’s true scale, showing why the deadliest climate disaster can pass quietly behind ordinary causes of death.
A tiny implant paired with camera glasses can return useful central vision to some people with advanced macular degeneration, and Europe has cleared its sale.
Between 19 and 34 per cent of people with diabetes will develop a foot ulcer. Once one has happened, five-year mortality runs at 50 to 70 per cent. Almost nobody is told this, and the prevention costs the price of looking.
WHO’s new figures show real progress despite a billion more vehicles, while poorer countries and vulnerable road users remain on the wrong side of the decline.